2-177234226-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_006164.5(NFE2L2):c.91G>A(p.Gly31Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (no stars).
Frequency
Genomes: not found (cov: 33)
Consequence
NFE2L2
NM_006164.5 missense
NM_006164.5 missense
Scores
14
3
2
Clinical Significance
Conservation
PhyloP100: 7.57
Genes affected
NFE2L2 (HGNC:7782): (NFE2 like bZIP transcription factor 2) This gene encodes a transcription factor which is a member of a small family of basic leucine zipper (bZIP) proteins. The encoded transcription factor regulates genes which contain antioxidant response elements (ARE) in their promoters; many of these genes encode proteins involved in response to injury and inflammation which includes the production of free radicals. Multiple transcript variants encoding different isoforms have been characterized for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.827
PP5
Variant 2-177234226-C-T is Pathogenic according to our data. Variant chr2-177234226-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 445150.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFE2L2 | NM_006164.5 | c.91G>A | p.Gly31Arg | missense_variant | 2/5 | ENST00000397062.8 | NP_006155.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NFE2L2 | ENST00000397062.8 | c.91G>A | p.Gly31Arg | missense_variant | 2/5 | 1 | NM_006164.5 | ENSP00000380252.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Immunodeficiency, developmental delay, and hypohomocysteinemia Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 28, 2018 | - - |
Colorectal cancer Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Oxford Haemato-Oncology Service, Oxford University Hospitals NHS Foundation Trust | Nov 27, 2017 | Deregulation in NFE2L2 have been associated with anti-oxydant metabolism deregulation during chemotherapy. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;T;.;.;.;T;T;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;D;D;D;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;M;.;.;.;.;.;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D;D;.;N;D;.;D;D;.
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;.;D;D;.;D;D;.
Sift4G
Pathogenic
D;D;D;D;.;.;D;.;D;.
Polyphen
1.0
.;D;.;.;.;.;.;.;D;.
Vest4
MutPred
0.58
.;Gain of solvent accessibility (P = 0.0055);.;.;.;.;.;.;.;.;
MVP
MPC
0.69
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at